Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Assets Average (2022 - 2025)

Historic Assets Average for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $33.5 million.

  • Atara Biotherapeutics' Assets Average fell 7420.32% to $33.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year decrease of 7420.32%. This contributed to the annual value of $137.3 million for FY2024, which is 4932.83% down from last year.
  • As of Q3 2025, Atara Biotherapeutics' Assets Average stood at $33.5 million, which was down 7420.32% from $49.5 million recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Assets Average ranged from a high of $416.7 million in Q2 2022 and a low of $33.5 million during Q3 2025
  • In the last 4 years, Atara Biotherapeutics' Assets Average had a median value of $171.3 million in 2023 and averaged $209.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 2892.76% in 2024, then tumbled by 7420.32% in 2025.
  • Over the past 4 years, Atara Biotherapeutics' Assets Average (Quarter) stood at $372.4 million in 2022, then crashed by 52.43% to $177.1 million in 2023, then dropped by 28.93% to $125.9 million in 2024, then tumbled by 73.36% to $33.5 million in 2025.
  • Its Assets Average stands at $33.5 million for Q3 2025, versus $49.5 million for Q2 2025 and $85.6 million for Q1 2025.